The US review ordered by Trump concludes that the NHS puberty blocker trial is not very ethical
A review of the US government.Non -ethical “ and warning of “Significant damage.“The report published by the Department of Health and Human Services later today, echoes the findings of Cass review, but goes further in its warnings. Researchers say that the high risk of infertility of puberty blockers in particular should avoid its current use in trials …
CASS recommended a puberty blockers to establish benefits and damage: a process that NHS is now designing. He thought that the United States report concludes that the trial “Conflict with ethical standards well established for the investigation of human subjects.” Oof …
Althegh, the authors of the review remain in anonymity, for fear of the threats of gender ideologues, a source close to the process is openly critical with Trump, saying: “We have an option between bad and worse: the bad thing is to let the Trump administration approach this, it is worse to allow this field of medicine not to regulate completely and see sterilized children and the breasts amputated with zero responsibility.” The report concludes:
“We can be safe in the ordinary sense of” certain “that thesis interventions cause harm, even if we have no evidence of” high certainty “in the technical sense.”
The NHS looks at the heat from the other side of the pond …
Read the full report below:
